400 related articles for article (PubMed ID: 9883382)
41. A five-year evaluation of NORPLANT II implants in China.
Gu S; Du M; Zhang L; Liu Y; Wang S; Sivin I
Contraception; 1994 Jul; 50(1):27-34. PubMed ID: 7924320
[TBL] [Abstract][Full Text] [Related]
42. Norplant subdermal contraceptive system: experience in Taiwan.
Tseng LH; Lee TY; Yang YS; Ko TM; Chuang SM
Contraception; 1996 Mar; 53(3):177-80. PubMed ID: 8689883
[TBL] [Abstract][Full Text] [Related]
43. Management of irregular uterine bleeding and spotting associated with Norplant.
Archer DF; Philput CA; Weber ME
Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
[TBL] [Abstract][Full Text] [Related]
44. Levonorgestrel contraceptive implants in female patients 14 to 21 years old.
Suman VJ; Van Winter JT; Evans MP; Simmons PS; Jacobsen SJ; Manolis AL
Mayo Clin Proc; 1998 Jan; 73(1):10-6. PubMed ID: 9443673
[TBL] [Abstract][Full Text] [Related]
45. Preliminary experience with Norplant in an inner city population.
Cullins VE; Blumenthal PD; Remsburg RE; Huggins GR
Contraception; 1993 Feb; 47(2):193-203. PubMed ID: 8449019
[TBL] [Abstract][Full Text] [Related]
46. Acceptability of Norplant implants for fertility regulation in Singapore.
Singh K; Viegas OA; Fong YF; Ratnam SS
Contraception; 1992 Jan; 45(1):39-47. PubMed ID: 1591920
[TBL] [Abstract][Full Text] [Related]
47. Contraceptive implant use among inner city teens.
Glantz S; Schaff E; Campbell-Heider N; Glantz JC; Bartlett M
J Adolesc Health; 1995 May; 16(5):389-95. PubMed ID: 7662690
[TBL] [Abstract][Full Text] [Related]
48. Depressive symptoms and Norplant contraceptive implants.
Westhoff C; Truman C; Kalmuss D; Cushman L; Rulin M; Heartwell S; Davidson A
Contraception; 1998 Apr; 57(4):241-5. PubMed ID: 9649915
[TBL] [Abstract][Full Text] [Related]
49. Education and counseling for Norplant users.
Hinkle LT
J Obstet Gynecol Neonatal Nurs; 1994 Jun; 23(5):387-91. PubMed ID: 8083779
[TBL] [Abstract][Full Text] [Related]
50. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
51. Levonorgestrel implant use among adolescents.
Mashburn M
J Pediatr Health Care; 1994; 8(6):255-60. PubMed ID: 7799199
[TBL] [Abstract][Full Text] [Related]
52. Hormonal implants: contraception for a new century.
Darney PD
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
[TBL] [Abstract][Full Text] [Related]
53. Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience.
Grubb GS; Moore D; Anderson NG
Contraception; 1995 Nov; 52(5):287-96. PubMed ID: 8585885
[TBL] [Abstract][Full Text] [Related]
54. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
Fleming D; Davie J; Glasier A
Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
[TBL] [Abstract][Full Text] [Related]
55. Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use.
Berenson AB; Wiemann CM; Rickerr VI; McCombs SL
Am J Obstet Gynecol; 1997 Mar; 176(3):586-92. PubMed ID: 9077611
[TBL] [Abstract][Full Text] [Related]
56. A two-year study of acceptability, side effects, and effectiveness of Norplant and Norplant-2 implants in the People's Republic of China.
Gu SJ; Du MG; Yuan DY; Zhang LD; Xu MF; Liu YL; Wang SH; Wu SL; Wang PZ; Gao YL
Contraception; 1988 Dec; 38(6):641-57. PubMed ID: 3146463
[TBL] [Abstract][Full Text] [Related]
57. Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants.
Sivin I; Lähteenmäki P; Ranta S; Darney P; Klaisle C; Wan L; Mishell DR; Lacarra M; Viegas OA; Bilhareus P; Koetsawang S; Piya-Anant M; Diaz S; Pavez M; Alvarez F; Brache V; LaGuardia K; Nash H; Stern J
Contraception; 1997 Feb; 55(2):81-5. PubMed ID: 9071516
[TBL] [Abstract][Full Text] [Related]
58. Three-year experience with NORPLANT subdermal contraception.
Sivin I; Sanchez FA; Diaz S; Holma P; Coutinho E; McDonald O; Robertson DN; Stern J
Fertil Steril; 1983 Jun; 39(6):799-808. PubMed ID: 6406273
[TBL] [Abstract][Full Text] [Related]
59. Norplant-2 subdermal contraceptive system: experience in Taiwan.
Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
[TBL] [Abstract][Full Text] [Related]
60. Adolescents and Norplant: preliminary findings of side effects.
Kozlowski KJ; Rickert VI; Hendon A; Davis P
J Adolesc Health; 1995 May; 16(5):373-8. PubMed ID: 7662687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
